A UHPLC METHOD FOR SERTRALINE DETERMINATION

Purpose: To develop and implement a UHPLC method for quantitative determination of sertraline in biological samples – mostly human blood and urine. Material&Methods: Blood and urine samples available from Laboratory of analytical toxicology and Clinic for intensive treatment of acute intoxicati...

Full description

Bibliographic Details
Main Authors: Georgi Bonchev, Snezha Zlateva, Petko Marinov, Marieta Yovcheva, Ivaylo Vazharov
Format: Article
Language:English
Published: Peytchinski Publishing 2017-11-01
Series:Journal of IMAB
Subjects:
Online Access:http://www.journal-imab-bg.org/issues-2017/issue4/JofIMAB-2017-23-4p1765-1768.pdf
_version_ 1818051255052795904
author Georgi Bonchev
Snezha Zlateva
Petko Marinov
Marieta Yovcheva
Ivaylo Vazharov
author_facet Georgi Bonchev
Snezha Zlateva
Petko Marinov
Marieta Yovcheva
Ivaylo Vazharov
author_sort Georgi Bonchev
collection DOAJ
description Purpose: To develop and implement a UHPLC method for quantitative determination of sertraline in biological samples – mostly human blood and urine. Material&Methods: Blood and urine samples available from Laboratory of analytical toxicology and Clinic for intensive treatment of acute intoxications and toxicoallergies were used during method validation and case monitoring. Analytical identification of sertraline and/or metabolites was done by GC-MS. Gas chromatography coupled with flame ionization detection was used for alcohols/volatiles screening of clinical samples. Ultra high-performance liquid chromatography system in tandem with diode-array detector has been used as the main quantitative instrument. Results: After critical consideration of available reference data a carefully set of experimental conditions for sertraline extraction and UHPLC determination were adopted and optimized. Preliminary liquid-phase sample purification was applied. Zorbax Extend-C18 column (150 x 4.6 mm, 5 µm) was used under isocratic conditions with phosphate buffer (pH 2.7; 10 mM) containing 1.5 ml L–1 triethylamine – acetonitrile (65:35, v/v) at 20oC, at the flow-rate of 1.0 mL/min and UV detection at 220 nm. This method was validated for the determination of sertraline in human plasma/serum samples (70% recovery). Conclusions: A simple yet sensitive and reliable method for sertraline determination was introduced. Linearity over 20-1000 ng mL–1 range was shown; LOQ was 20 ng mL–1. The method was clinically applied for monitoring the blood sertraline levels during a course of detoxication of a female patient.
first_indexed 2024-12-10T11:06:27Z
format Article
id doaj.art-ee57892e355b4f93b52afa8002c48649
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-12-10T11:06:27Z
publishDate 2017-11-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-ee57892e355b4f93b52afa8002c486492022-12-22T01:51:33ZengPeytchinski PublishingJournal of IMAB1312-773X2017-11-012341765176810.5272/jimab.2017234.1765A UHPLC METHOD FOR SERTRALINE DETERMINATIONGeorgi Bonchev0Snezha Zlateva1Petko Marinov2Marieta Yovcheva3Ivaylo Vazharov4Clinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic of Internal Diseases, Naval Hospital – Varna, Military Medical Academy, Bulgaria.Purpose: To develop and implement a UHPLC method for quantitative determination of sertraline in biological samples – mostly human blood and urine. Material&Methods: Blood and urine samples available from Laboratory of analytical toxicology and Clinic for intensive treatment of acute intoxications and toxicoallergies were used during method validation and case monitoring. Analytical identification of sertraline and/or metabolites was done by GC-MS. Gas chromatography coupled with flame ionization detection was used for alcohols/volatiles screening of clinical samples. Ultra high-performance liquid chromatography system in tandem with diode-array detector has been used as the main quantitative instrument. Results: After critical consideration of available reference data a carefully set of experimental conditions for sertraline extraction and UHPLC determination were adopted and optimized. Preliminary liquid-phase sample purification was applied. Zorbax Extend-C18 column (150 x 4.6 mm, 5 µm) was used under isocratic conditions with phosphate buffer (pH 2.7; 10 mM) containing 1.5 ml L–1 triethylamine – acetonitrile (65:35, v/v) at 20oC, at the flow-rate of 1.0 mL/min and UV detection at 220 nm. This method was validated for the determination of sertraline in human plasma/serum samples (70% recovery). Conclusions: A simple yet sensitive and reliable method for sertraline determination was introduced. Linearity over 20-1000 ng mL–1 range was shown; LOQ was 20 ng mL–1. The method was clinically applied for monitoring the blood sertraline levels during a course of detoxication of a female patient.http://www.journal-imab-bg.org/issues-2017/issue4/JofIMAB-2017-23-4p1765-1768.pdfsertralineZoloftHPLC determinationdrug monitoring
spellingShingle Georgi Bonchev
Snezha Zlateva
Petko Marinov
Marieta Yovcheva
Ivaylo Vazharov
A UHPLC METHOD FOR SERTRALINE DETERMINATION
Journal of IMAB
sertraline
Zoloft
HPLC determination
drug monitoring
title A UHPLC METHOD FOR SERTRALINE DETERMINATION
title_full A UHPLC METHOD FOR SERTRALINE DETERMINATION
title_fullStr A UHPLC METHOD FOR SERTRALINE DETERMINATION
title_full_unstemmed A UHPLC METHOD FOR SERTRALINE DETERMINATION
title_short A UHPLC METHOD FOR SERTRALINE DETERMINATION
title_sort uhplc method for sertraline determination
topic sertraline
Zoloft
HPLC determination
drug monitoring
url http://www.journal-imab-bg.org/issues-2017/issue4/JofIMAB-2017-23-4p1765-1768.pdf
work_keys_str_mv AT georgibonchev auhplcmethodforsertralinedetermination
AT snezhazlateva auhplcmethodforsertralinedetermination
AT petkomarinov auhplcmethodforsertralinedetermination
AT marietayovcheva auhplcmethodforsertralinedetermination
AT ivaylovazharov auhplcmethodforsertralinedetermination
AT georgibonchev uhplcmethodforsertralinedetermination
AT snezhazlateva uhplcmethodforsertralinedetermination
AT petkomarinov uhplcmethodforsertralinedetermination
AT marietayovcheva uhplcmethodforsertralinedetermination
AT ivaylovazharov uhplcmethodforsertralinedetermination